Skip to main content

Table 5 Predictive factors for disease free survival

From: A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases

  DFS  
Patients HR : (95% CI) (p)
Gender: Female 1.17: (0.74 – 1.86) 0.51
Age at SBRT 65+ 0.72: (0.46 – 1.15) 0.17
Adenocarcinoma Histology: 1.28 : (0.75 – 2.19) 0.36
Lesions : pulmonary 0.47 : (0.23 – 0.95) 0.02
Number of lesions : 3+ 1.17 : (0.70 – 1.98) 0.55
Number of hepatic lesions : 3+ 1.40 : (0.79 – 2.48) 0.25
Timing of Metastases: < one year 0.67: (0.37 - 1.22) 0.19
    More than 1 year 1.04: (0.60 – 1.79) 0.90
Prior chemotherapy 4.51: (1.10 – 18.47) 0.007
3+ chemotherapies before SBRT : 1.20: (0.63 – 2.25) 0.59
Prior PD with previous CT 1.31: (0.74 – 2.32) 0.37